Dose-response effect of depot leuprolide acetate on serum androgens In hirsute women

被引:6
|
作者
Rittmaster, RS [1 ]
Arab, DM [1 ]
Lehman, L [1 ]
机构
[1] DALHOUSIE UNIV,DEPT MED,HALIFAX,NS,CANADA
基金
英国医学研究理事会;
关键词
hirsutism; polycystic ovary syndrome; gonadotropin-releasing hormone agonist; leuprolide acetate; androgens; estrogen replacement;
D O I
10.1016/S0015-0282(16)58259-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the dose of leuprolide acetate (LA) needed to maximally suppress serum androgens in hirsute women. Design: Prospective, dose-escalation study. Setting: Outpatient endocrinology clinic. Patients: Eight hyperandrogenic women with moderate to severe hirsutism. Interventions: A LA dose-response study was done in women receiving depot LA plus estrogen-progestin replacement. Main Outcome Measures: Serum concentrations of T, androstenedione (A), and basal and GnRH-stimulated LH. Results: The lowest LA dose (3.75 mg/mo) suppressed serum T by 62% +/- 6% and A by 56% +/- 7%. No further decrease in serum androgens was seen with doses up to 15 mg/mo. Maximal suppression of basal and stimulated LH was also seen with the lowest dose of LA. Conclusions: As opposed to results previously published in children with precocious puberty, the 3.75 mg dose of depot LA is sufficient to maximally suppress serum androgens in hyperandrogenic women.
引用
收藏
页码:912 / 915
页数:4
相关论文
共 50 条
  • [21] SERUM-SOLUBLE CD23 IN PATIENTS WITH ENDOMETRIOSIS AND THE EFFECT OF TREATMENT WITH DANAZOL AND LEUPROLIDE ACETATE DEPOT INJECTION
    ODUKOYA, OA
    BANSAL, A
    WILSON, AP
    WEETMAN, AP
    COOKE, ID
    HUMAN REPRODUCTION, 1995, 10 (04) : 942 - 946
  • [22] PHARMACOKINETICS, ENDOCRINE AND ANTITUMOUR EFFECTS OF LEUPROLIDE DEPOT (TAP-144-SR) IN ADVANCED PROSTATIC-CANCER - A DOSE-RESPONSE EVALUATION
    MAZZEI, T
    MINI, E
    EANDI, M
    REALI, EF
    FIORETTO, L
    BARTOLETTI, R
    RIZZO, M
    CALABRO, G
    PERITI, P
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1989, 15 (08) : 373 - 387
  • [23] Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women
    Grigorova, Miglena
    Sherwin, Barbara B.
    Tulandi, Togas
    PSYCHONEUROENDOCRINOLOGY, 2006, 31 (08) : 935 - 947
  • [24] DOSE-RESPONSE EFFECT
    SMITH, PJ
    HINDMARSH, PC
    BROOK, CGD
    ACTA PAEDIATRICA SCANDINAVICA, 1987, : 117 - 117
  • [25] EFFECTS OF CYPROTERONE-ACETATE PLUS ETHINYLESTRADIOL LOW-DOSE ON PLASMA ANDROGENS AND LIPIDS IN MILDLY HIRSUTE OR ACNEIC YOUNG-WOMEN
    VERMEULEN, A
    RUBENS, R
    CONTRACEPTION, 1988, 38 (04) : 419 - 428
  • [26] New low dose depot medroxyprogesterone acetate subcutaneous injection is equivalent to leuprolide acetate for endometriosis-associated pain.
    Archer, DF
    Luciano, A
    Carson, S
    Vilos, G
    FERTILITY AND STERILITY, 2004, 82 : S71 - S71
  • [27] Increase in serum leptin concentrations among women with endometriosis during danazol and leuprolide depot treatments
    Matalliotakis, IM
    Koumantaki, YG
    Neonaki, MA
    Goumenou, AG
    Koumantakis, GE
    Kyriakou, DS
    Koumantakis, EE
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (01) : 58 - 62
  • [28] EFFECT OF MEGESTROL-ACETATE ON QUALITY-OF-LIFE IN A DOSE-RESPONSE TRIAL IN WOMEN WITH ADVANCED BREAST-CANCER
    KORNBLITH, AB
    HOLLIS, DR
    ZUCKERMAN, E
    LYSS, AP
    CANELLOS, GP
    COOPER, MR
    HERNDON, JE
    PHILLIPS, CA
    ABRAMS, J
    AISNER, J
    NORTON, L
    HENDERSON, C
    HOLLAND, JC
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) : 2081 - 2089
  • [29] What Is the Best Parameter to Decide the Initial Dose of Depot Leuprolide Acetate in Girls with Idiopathic Central Precocious Puberty?
    Vuralli, Dogus
    Alikasifoglu, Ayfer
    Lyigun, Irem
    Canoruc, Dicle
    Ozon, Alev
    Gonc, Nazli
    Kandemir, Nurgun
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 102 - 103
  • [30] DOSE-RESPONSE STUDY OF THE EFFECT OF CIPROFIBRATE ON SERUM LIPOPROTEIN CONCENTRATIONS IN HYPERLIPOPROTEINEMIA
    OLSSON, AG
    ORO, L
    ATHEROSCLEROSIS, 1982, 42 (2-3) : 229 - 243